The largest database of trusted experimental protocols

4 protocols using gfp 11 814 460 001

1

Comprehensive Chromatin Immunoprecipitation and Protein Interaction Mapping

Check if the same lab product or an alternative is used in the 5 most similar protocols
MNase and all chemicals were purchased from Sigma-Aldrich unless otherwise specified. DNA modifying enzymes were from Roche Applied Sciences. Pladienolide B was from Santa Cruz Biotechnology, the ATR inhibitor VE821 from TINIB-Tools, and the ATM inhibitor KU55933 and DNA-PK inhibitor NU7441 from R&D Systems. Antibodies used were against: PRP8 (H300), XPA/p62 (FL-273), p89/XPB (S-19) and β-Tubulin from Santa Cruz Biotechnology; SNRPC/U1C (NBP1-96048), NHP2L1 (NBP1-32732), SF3a1 (NB100-79847), SF3b2 (NV100-79843), RNaseH1 (NBP2-20171), and RNaseH2A (NBP1-76981) from Novus Biologicals; SNRNP40 (SAB2701506) and SRSF2/SC35 (clone SC-35) from Sigma; SNRPA/U1A (3F9-1F7) from ABGENT; PRPF3 (ab187535), RNPII CTD (phospho-S2) (ab5095), RNAPII (ab5095), PCNA (PC-10), Ki67 (ab833) from abcam®; CPD (TDM-2) from MBL International; GFP (11 814 460 001) from Roche; H2A (07-146) from Millipore Corp.; phosphor-ATM(1981)(05-740) from Upstate Biotechnology, Phospho-CHK2(Thr68) (2661) from Cell Signaling. Anti-XPC (rabbit-polyclonal ab) was in-house developed. Odyssey-compatible IRDye680- and IRDye800–conjugated secondary antibodies were from LI-COR. Secondary antibodies conjugated to Alexa Fluorochromes-488, -568, -594 and-647 were from Invitrogen. GFP-tagged proteins were immunoprecipitated with GFP-Trap® beads (ChromoTek).
+ Open protocol
+ Expand
2

Antibody-Based Protein Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies: Phospho-Smad2 (#3108, Cell Signaling Tech. 1/1000), phospho-Smad3(#9520, Cell Signaling Tech. 1/1000), phospho-Stat3 (#9131, Cell Signaling Tech. 1/1000), phospho-Jak2 (#3771, Cell Signaling Tech. 1/1000), Snail (#3879, Cell Signaling Tech. 1/1000), EEA1 (#C45B10, Cell Signaling Tech. 1/100) and total Stat3(#4904, Cell Signaling Tech. 1/1000) were purchased from Cell Signaling Technology; SMAD2/3 (610843, BD Biosciences, 1/1000), anti-myc (sc789, 1/1000 and 9E10, sc40, 1/1000), TβRI (sc398, 1/500) Lamin B (sc6217, 1/1000) TβRII (sc17792, 1/500), FKBP12 (sc6174, 1/500), GAPDH (sc32233, 1/1000) and GPR50 (sc50590, 1/500) came from Santa Cruz Biotechnology. Monoclonal and polyclonal Flag-Antibodies were used from Sigma-Aldrich (M2-F3165, 1/1000, and F7425, 1/1000). HA (11867423001, 1/1000) and GFP (11814460001, 1/2000) antibodies were used from Roche. Anti-Tubulin was purchased from AbD Serotec (MCA77G, 1/2000). GPR50 antibody7 was produced by Kernov Antibody Services (1/1000)49 (link). Polyclonal Anti GPR50 (H00009248-B01P, 1/500) was purchased from Novus Biologicals. Anti TGFβRI-pS165 (ab112095, 1/500) was purchased from Abcam. All antibodies were employed according to the recommended dilutions for either immunoprecipitation or western blotting.
Reagents: FK506 and SB431542 were purchased from Sigma Aldrich and recombinant TGFβ-1 was purchased from Peprotech.
+ Open protocol
+ Expand
3

DYRK1B Antibody Production and Validation

Check if the same lab product or an alternative is used in the 5 most similar protocols
DYRK1B antibodies produced in rabbits using the immunogen CGLRGVPQSTAASS for the Western blot antibody and MAVPPGHGPFSGC for the antibody used for immunoprecipitation assays were provided by AstraZeneca (Alderley Park, Macclesfield, UK) and were described previously. The p-S421-DYRK1B antibody, also from AstraZeneca, was produced in rabbits immunised with the BSA conjugated phospho-peptide ac-CGEPAARI(P)SPLGALQHG-nh2, prepared using standard procedures [37 ]. Antibodies specific for p-T202/Y204-ERK1/2 (9106), ERK1/2 (4695), p-T180/Y182-p38 (9211), p-T183/Y185-JNK (9251), pT286-cyclin D1 (2921), p-S33/S37/T41-β Catenin (9561) were from Cell Signaling Technologies; ERK1 (610031), HSP90 (610418) and β-Catenin (610153) were from BD Biosciences, β-actin (A5441) was from Sigma; GFP (11814460001) was from Roche; cyclin D1 (CC12) and Ras (OP40) were from Calbiochem. JNK1/3 (sc474) and ERK2 (sc154) were from Santa Cruz Biotechnology; Flag (MAB3118) was from Millipore; p38 antibody was provided by the Babraham Institute Monoclonal Antibody Facility.
+ Open protocol
+ Expand
4

Comprehensive Chromatin Immunoprecipitation and Protein Interaction Mapping

Check if the same lab product or an alternative is used in the 5 most similar protocols
MNase and all chemicals were purchased from Sigma-Aldrich unless otherwise specified. DNA modifying enzymes were from Roche Applied Sciences. Pladienolide B was from Santa Cruz Biotechnology, the ATR inhibitor VE821 from TINIB-Tools, and the ATM inhibitor KU55933 and DNA-PK inhibitor NU7441 from R&D Systems. Antibodies used were against: PRP8 (H300), XPA/p62 (FL-273), p89/XPB (S-19) and β-Tubulin from Santa Cruz Biotechnology; SNRPC/U1C (NBP1-96048), NHP2L1 (NBP1-32732), SF3a1 (NB100-79847), SF3b2 (NV100-79843), RNaseH1 (NBP2-20171), and RNaseH2A (NBP1-76981) from Novus Biologicals; SNRNP40 (SAB2701506) and SRSF2/SC35 (clone SC-35) from Sigma; SNRPA/U1A (3F9-1F7) from ABGENT; PRPF3 (ab187535), RNPII CTD (phospho-S2) (ab5095), RNAPII (ab5095), PCNA (PC-10), Ki67 (ab833) from abcam®; CPD (TDM-2) from MBL International; GFP (11 814 460 001) from Roche; H2A (07-146) from Millipore Corp.; phosphor-ATM(1981)(05-740) from Upstate Biotechnology, Phospho-CHK2(Thr68) (2661) from Cell Signaling. Anti-XPC (rabbit-polyclonal ab) was in-house developed. Odyssey-compatible IRDye680- and IRDye800–conjugated secondary antibodies were from LI-COR. Secondary antibodies conjugated to Alexa Fluorochromes-488, -568, -594 and-647 were from Invitrogen. GFP-tagged proteins were immunoprecipitated with GFP-Trap® beads (ChromoTek).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!